Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miguel Gutierrez-Jansen"'
Autor:
Cristina Bandera-García, Rocio Reina-Gonzalez, Miguel Gutierrez-Jansen, Inmaculada Lupiáñez-Pérez, Alfonso Hidalgo Hidalgo-Natera, Diego Lozano-Noriega, Ulises Salgado-Carvallo, Antonio Baca-Osorio, Rafael Poyato-Ramos, Leovigildo Ginel-Mendoza, Francisco Javier Navarro-Moya, María Paz Fernandez-Lara, Juana Morales-Naranjo
Publikováno v:
Trials
Trials, Vol 22, Iss 1, Pp 1-10 (2021)
Trials, Vol 22, Iss 1, Pp 1-10 (2021)
Background Oral anticoagulant drugs represent an essential tool in the prevention of thromboembolic events. The ones in widespread use are vitamin K antagonists, whose plasma level is monitored by measuring prothrombin time using the international no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746fca55e2a51b89df63c1e985702df6
http://europepmc.org/articles/PMC7798294
http://europepmc.org/articles/PMC7798294
Autor:
Antonio Baca-Osorio, Leovigildo Ginel-Mendoza, Francisco Javier Navarro-Moya, María Paz Fernandez-Lara, Diego Lozano-Noriega, Juana Morales-Naranjo, Rafael Poyato-Ramos, Miguel Gutierrez-Jansen, Cristina Bandera-García, Ulises Salgado-Carvallo, Rocio Reina-Gonzalez, Inmaculada Lupiáñez-Pérez, Alfonso Hidalgo Hidalgo-Natera
Background Oral anticoagulant drugs represent an essential tool in thrombo-embolic events prevention. Most used are vitamin K antagonists, whose plasma level is monitored by measuring prothrombin time using the International Normalized Ratio. If it t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0869b4b6bd38366f01953daa755333af
https://doi.org/10.21203/rs.3.rs-17348/v1
https://doi.org/10.21203/rs.3.rs-17348/v1
Autor:
Leovigildo Ginel-Mendoza, Alfonso Hidalgo-Natera, Rocío Reina-Gonzalez, Rafael Poyato-Ramos, Juana Morales-Naranjo, Inmaculada Lupiañez-Pérez, Antonio Baca-Osorio, Miguel Gutiérrez-Jansen, María Paz Fernández-Lara, Diego Lozano-Noriega, Ulises Salgado-Carvallo, Cristina Bandera-García, Francisco Javier Navarro-Moya
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Oral anticoagulant drugs represent an essential tool in the prevention of thromboembolic events. The ones in widespread use are vitamin K antagonists, whose plasma level is monitored by measuring prothrombin time using the interna
Externí odkaz:
https://doaj.org/article/47d2760493694c9984c4c16a751e59ad